HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Christopher Amos Selected Research
Christopher Amos Research Topics
Disease
7
Neoplasms (Cancer)
04/2024 - 08/2009
3
Lung Neoplasms (Lung Cancer)
09/2023 - 10/2016
2
Melanoma (Melanoma, Malignant)
04/2024 - 10/2018
2
Breast Neoplasms (Breast Cancer)
04/2024 - 02/2009
2
Adenocarcinoma of Lung
01/2023 - 11/2020
2
Rheumatoid Arthritis
03/2015 - 05/2006
1
Hypertension (High Blood Pressure)
04/2024
1
Pancreatic Neoplasms (Pancreatic Cancer)
04/2024
1
Genomic Instability
01/2023
1
Ganglion Cysts (Ganglion)
01/2022
1
Refractive Errors (Refractive Error)
01/2022
1
Leukemia
05/2012
1
Chromosome Aberrations (Chromosome Abnormalities)
05/2012
1
Prostatic Neoplasms (Prostate Cancer)
08/2009
1
Infections
05/2008
1
Hereditary Neoplastic Syndromes (Cancer Syndrome, Hereditary)
08/2007
Drug/Important Bio-Agent (IBA)
2
Transcription Factors (Transcription Factor)
IBA
09/2023 - 01/2012
2
RNA (Ribonucleic Acid)
IBA
01/2023 - 11/2020
2
MicroRNAs (MicroRNA)
IBA
11/2022 - 09/2014
2
Genetic Markers (Genetic Marker)
IBA
10/2016 - 08/2009
2
DNA (Deoxyribonucleic Acid)
IBA
05/2012 - 08/2007
1
Proteins (Proteins, Gene)
FDA Link
04/2024
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
01/2023
1
Retinaldehyde (Retinal)
IBA
01/2022
1
Tyrosine Kinase Inhibitors
IBA
11/2020
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
11/2020
1
Gefitinib (Iressa)
FDA Link
11/2020
1
Sorafenib (BAY 43-9006)
FDA Link
11/2020
1
Formaldehyde (Formol)
FDA Link
10/2018
1
Paraffin
IBA
10/2018
1
Smoke
IBA
10/2016
1
Carcinogens
IBA
10/2016
1
Cytochrome P-450 Enzyme System (Cytochrome P450)
IBA
10/2016
1
Nicotine
FDA Link
10/2016
1
acetyl 4-aminosalicylic acid
IBA
03/2015
1
Anti-Citrullinated Protein Antibodies
IBA
03/2015
1
Osteopontin
IBA
03/2015
1
Messenger RNA (mRNA)
IBA
09/2014
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
01/2012
1
Phosphotransferases (Kinase)
IBA
01/2012
1
Indicators and Reagents (Reagents)
IBA
02/2009
1
HLA Antigens (Human Leukocyte Antigens)
IBA
05/2008
1
Ligands
IBA
05/2008
1
HLA-C Antigens (HLA-C)
IBA
05/2008
1
Natural Killer Cell Receptors
IBA
05/2008
1
HLA-DRB1 Chains (HLA DRB1)
IBA
05/2006
Therapy/Procedure
1
Therapeutics
11/2020